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Most equine lower respiratory diseases present as increased airway neutrophilia, which 
can be detected in tracheal wash (TW) or bronchoalveolar lavage fluid (BALF) cytology 
samples. The aim was to compare the TW and BALF results in a population of client- 
owned horses with and without clinical respiratory disease signs. A secondary aim was 
to determine the sensitivity (Se) and specificity (Sp) of TW and BALF neutrophilia in 
detecting respiratory disease. The cutoff values for neutrophils were also evaluated. 
Retrospective data from 154 horses of various breeds that had been subject to both TW 
and bronchoalveolar lavage (BAL) sampling at rest during 2009−2015 were used. The 
horses were divided into three groups based on the presenting signs, physical examina-
tion, and endoscopy mucus score. Neutrophil counts of >20% in TW and >5% in BAL 
were considered abnormal. Cytology results between groups, correlations between TW 
and BALF cell types, and tracheal mucus score were analyzed. Two graph receiving 
operating characteristic (ROC) curves of the neutrophil percentage values of TW and 
BALF were created to determine the optimal cutoff values and to calculate the diag-
nostic Se and Sp for diagnosing airway inflammation in horses with and without clinical 
respiratory signs. The Se and Sp of TW and BALF neutrophil percentages were further 
estimated using a two-test one-population Bayesian latent class model. The two tests 
showed substantial agreement, and only 17.5% of the horses were classified differently 
(healthy vs. diseased). The neutrophil percentage was found to correlate between TW 
and BALF. The Se and Sp of TW were generally higher than for BAL when estimated 
with area under the curve or Bayesian model. Cutoff values of 17.7% for TW and 7% for 
BALF were indicated by the ROCs. We conclude that TW is a more sensitive and specific 
method in our patient population. We suggest that the current neutrophil cutoff values of 
20% for TW and 5% for BALF would still be appropriate to use in clinical diagnosis of air-
way inflammation. However, further studies with other cell types and in other populations 
are warranted to determine the best sampling method for individual horses.
Keywords: equine, bronchoalveolar lavage, tracheal wash, lung, respiratory
Abbreviations: AUC, area under the curve; BAL, bronchoalveolar lavage; BALF, bronchoalveolar lavage fluid; EIPH, exercise 
induced pulmonary hemorrhage; ROC, receiving operating characteristic; TW, tracheal wash.
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inTrODUcTiOn
Cytological analysis of tracheal wash (TW) and bronchoalveolar 
lavage fluid (BALF) is a common diagnostic procedure in equine 
practice when assessing the lower respiratory tract health of the 
horse (1, 2). The choice of the sampling method is related to the 
suspected disease process. TW is considered to give a better 
representation of the whole lung than bronchoalveolar lavage 
(BAL) and, therefore, often preferred in cases where an infec-
tious disease is suspected because secretions from the affected 
lung areas will collect in the trachea (3). The advantages of TW 
in clinical practice are its lower costs and the potential avoid-
ance of doping withdrawal times that arise from sedation and 
local anesthesia that are often administered during the BAL 
procedure to restrain the horse and suppress coughing (3). 
On the other hand, BAL is recommended in suspected diffuse 
non-bacterial lung disease, and it is considered to be a more 
sensitive technique for detecting lower airway inflammation 
(2, 4). Furthermore, BALF cytology may correlate better with 
lung histopathology results (4). In cases of uncertain etiology, 
performing both diagnostic tests simultaneously has been sug-
gested in order to achieve accurate diagnosis (3, 5).
Chronic lower airway inflammation in horses presents as 
two phenotypes: milder inflammatory airway disease (IAD) and 
more severe recurrent airway obstruction (RAO). Both IAD and 
RAO are considered to comprise the equine asthma syndrome 
(4, 6, 7). Equine asthma presents as neutrophilic inflamma-
tion of the lungs, although in mild asthma, eosinophilic and 
metachromatic disease phenotypes have also been recognized 
(4). Asthmatic horses have a chronic cough, nasal discharge, and 
exercise intolerance (4). The horses with severe asthma present 
with increased respiratory effort (4).
In addition to chronic respiratory signs, clinical diagnosis of 
equine asthma is often based on increased amount of tracheo-
bronchial mucus and inflammatory cells in the respiratory tract 
samples (2, 4). Most importantly, the elevated proportion of 
neutrophils in either TW or BAL fluid (BALF) is considered to 
indicate airway inflammation, and cutoff values for neutrophil 
percentage have been set at 20% for TW and 5% for BAL (3, 4). 
A 1% cutoff value for eosinophils in TW or BALF cytology and 
the cutoff of 2% for metachromatic cells in BALF cytology have 
also been considered (3, 4). Recently, new cutoff values of either 
>10% neutrophils, >5% mast cells, or >5% eosinophils for BALF 
cytology have been proposed for the diagnosis of airway inflam-
mation in order to allow more variability caused by the variation 
in sampling techniques, which still need to be standardized in 
horses (4, 8–11). Moreover, a consensus for a true gold standard 
for diagnosing equine airway inflammation is nevertheless still 
missing, and the suggested cutoff values are largely based on 
observational studies and expert opinion. To our knowledge, the 
sensitivity (Se) and specificity (Sp) of TW and BALF cytology 
have not been assessed in the diagnosis of respiratory disease.
In most previously published studies, TW and BALF cytol-
ogy results have shown poor correlation (5, 12–14). In contrast, 
Winder et al. (15, 16) reported correlations between the neutrophil 
percentages in TW and BALF samples. However, to our knowl-
edge, there are no recent studies published that compared TW 
and BALF cytology among horses of varying ages and disciplines 
that have naturally occurring respiratory disease. Therefore, the 
first aim of this study was to compare the two airway sampling 
methods in a population of client-owned horses with signs related 
to respiratory disease and in horses with no clinical respiratory 
signs. Due to the lack of previous studies regarding the Se and Sp 
of TW and BALF cytology, a secondary aim was to evaluate the 
cutoff values for neutrophils in TW and BALF in order to justify 
their use in clinical practice.
MaTerials anD MeThODs
animals
All horses (n = 154) that had been subject to both TW and BAL 
sampling at rest during 2009−2015 in Helsinki University Equine 
Teaching Hospital were included in this retrospective study. 
The horses were client-owned and brought to the hospital for 
investigation of the presenting problem. When possible, the 
owners were requested to bring an asymptomatic companion 
horse for research purposes. Prior to respiratory endoscopy and 
sampling, all horses underwent physical examination and hema-
tology analysis. The horses were divided into three groups based 
on the clinical signs and endoscopy findings. Group 1 included 
clinically healthy control horses without signs potentially related 
to respiratory disease (n = 33) that were sampled by TW and BAL 
methods for research purposes with the owners’ informed written 
consent. Thirteen of these horses were from the same properties 
than the symptomatic horses. Group 2 included horses that had at 
least one of the following signs: cough, nasal discharge, epistaxis, 
fever or poor performance, and did not belong to either Group 1 
or Group 3 (n = 79). Group 3 included horses that had both cough 
and nasal discharge at the time of the examination and/or highest 
mucus score (3/3) during endoscopy that confirmed respiratory 
disease (n = 42). Only one horse had mucus score 3/3 without 
clinical signs reported by the owner. Retrospective patient data 
were used to identify and categorize the symptomatic horses, and 
the data were deidentified prior to use. The study was carried out 
in accordance with the recommendations of the Finnish Animal 
Experiment Board (asymptomatic horses) and Viikki Ethics 
Committee (symptomatic horses). The protocol was approved by 
the Finnish Animal Experiment Board.
TW collection
Horses were restrained in stocks and sedated using intravenous 
detomidine (0.005−0.01  mg/kg, Domosedan®, Oriola, Espoo, 
Finland) and butorphanol (0.005−0.02  mg/kg, Butodol®, MSD 
Animal Health, Boxmeer, Netherlands). A twitch was used to 
restrain the horse when needed. Horses were sampled without 
prior exercise (at least 12 h). A 220 cm long, 11 mm diameter 
video endoscope (Pentax, Tokyo, Japan) was passed via the ventral 
nasal meatus to the pharynx and then advanced into the trachea 
via the rima glottidis. The amount and nature of the tracheal 
mucus deposits were observed and graded semiquantitatively as 
0 (none), 1 (mild), 2 (moderate), and 3 (marked). The endoscope 
was advanced to the mid-cervical trachea, and 10−20 mL of ster-
ile 0.9% saline at room temperature was injected through either a 
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single lumen polypropylene catheter or a double lumen catheter 
(Mila International, Erlanger, KY, USA) that was advanced to 
the trachea through the biopsy channel of the endoscope. After 
saline injection, the endoscope was advanced until the curvature 
of the distal trachea and the deposit of the mucus and saline 
were observed at the site of the thoracic inlet. As much fluid as 
possible was aspirated via the catheter. Samples were submitted 
for the laboratory analysis and were processed within 15 min of 
collection.
Bronchoalveolar lavage
Immediately following the transendoscopic TW procedure, BAL 
was performed. The endoscope was advanced further to the tra-
cheal bifurcation, and 40−60 mL of 1% lidocaine or mepivacaine 
was injected onto the carina and the right mainstem bronchi to 
decrease coughing. The endoscope was advanced further to the 
right caudodorsal lobe until significant resistance was noted, 
and the endoscope was wedged into a small bronchus. Then, 
240−360 mL of sterile 0.9% isotonic saline at room temperature 
was injected through the biopsy channel in one single volume 
followed by immediate aspiration. Syringes with the retrieved 
BALF samples were immediately placed on ice and submitted 
to laboratory analysis within 30 min of their collection. Samples 
were considered adequate when they contained a foamy sur-
factant layer. No samples had to be discarded due to inadequate 
quality.
cytological analysis of TW and BalF 
samples
Slides of the TW samples were prepared for differential cell 
counts by centrifugation of undiluted samples and subsequent 
smear of the cell pellet. Pooling the fluid from the syringes and 
cytocentrifugation (Thermo Scientific Cytospin 4 centrifuge; 
Thermo Fisher Scientific, Waltham, MA, USA) of undiluted 
samples was used for the BALF. All slides were stained with the 
May–Grünwald–Giemsa stain. A single experienced blinded 
person performed the differential counts of inflammatory cells 
by counting 300 cells from both TW and BALF slides. The 
analysis results for each cell type were expressed as a percentage 
of total cells.
statistical analyses
Statistical analyses were performed using the statistical software 
SPSS 22.0 (IBM SPSS Statistical Package version 22, New York, 
NY, USA). A Kolmogorov–Smirnov test and Q–Q plots were 
used to assess the normality of the data. For most variables, the 
data were not normally distributed; therefore, non-parametric 
tests were used. Differences between the three groups for age and 
TW and BALF cytology were analyzed using a Kruskal–Wallis 
one-way analysis of variance, and for pairwise comparisons 
Dunn’s procedure (17) with a Bonferroni adjustment was used. 
Correlations between the tracheal mucus score and the different 
cell types for TW and BALF were examined by calculating the 
Spearman’s correlation coefficient with a Bonferroni adjustment 
for multiple comparisons. Differences were considered significant 
at P < 0.05.
evaluation of TW and Bal Test results  
for neutrophils
The testing was performed using the currently accepted cutoff 
values for neutrophil percentage where >20% in TW and >5% 
in BALF were considered abnormal (3, 4). The Fisher’s exact 
test was used for comparison of the TW and BAL test results 
(i.e., diseased or non-diseased as based on the cutoffs) for all 
horses. A kappa value was calculated using EpiTools1 and fol-
lowed the guideline values for interpretation: ≤0 poor, 0.01–0.2 
slight, 0.21–0.4 fair, 0.41–0.6 moderate, 0.61–0.8 substantial, and 
0.81–1 almost perfect to perfect agreement (18). The kappa value 
was then used to compare the agreement between the two sam-
pling procedures in the population that were beyond chance. Two 
graph receiving operating characteristic (ROC) curves were cre-
ated and the area under the curve (AUC) calculated with EpiTools 
(see text footnote 1) for neutrophil percentage values in Group 
1 (asymptomatic) and Group 3 (most severe signs) to find the 
optimal cutoff values (Youden’s J value) for TW and BALF within 
this population of horses and the corresponding diagnostic Se 
and Sp values to distinguish non-diseased from the diseased. For 
the interpretation of the AUC, the following guideline values were 
used (19): 0.5 non-informative, 0.5 < AUC ≤ 0.7 less accurate, 
0.7  <  AUC  ≤  0.9 moderately accurate, 0.9  <  AUC  <  1 highly 
accurate, and AUC = 1 perfect test. The Fisher’s exact test was 
rerun with the optimal cutoff values obtained from the ROCs for 
only Group 2 (the most heterogeneous group) for comparison of 
the TW and BAL test results (diseased or non-diseased based on 
the cutoff values).
Due to the lack of a true gold standard for evaluating equine 
airway inflammation, Se and Sp of TW and BALF neutrophil 
percentages were further estimated by a two-dependent test one-
population Bayesian latent class model (20). The model allowed 
for a conditional dependence between TW and BAL results, since 
both TW and BAL samples were obtained from the airways of 
same animals, and they were considered related. The model was 
run in OpenBUGS© 3.2.3 rev 10122 using code described in 
Branscum et al. (21) and available elsewhere.3 The model requires 
informative prior data for at least one test to ensure adequate iden-
tification. Expert opinions of the first and last authors were used 
for estimating the prior values for prevalences in the two popula-
tions (Group 1 and Group 3) and for Se and Sp of the TW test. The 
used mode estimates for prevalence (p) of true respiratory disease 
among the studied populations of horses were for the diseased 
population (Group 3) p1 95% (95% sure > 90%) and for the non-
diseased population (Group 1) p2 10% (95% sure < 30%). The 
used estimates for Se and Sp to differentiate diseased from non-
diseased for the TW test were Se1 mode 95% (95% sure > 90%) 
and Sp1 mode 70% (95% sure > 60%) for diseased population 
and Se2 mode 85% (95% sure > 70%) and Sp2 mode 90% (95% 
sure  >  80%) for non-diseased population. The corresponding 
a and b values for beta-distributions were calculated using epi.
1 http://epitools.ausvet.com.au (accessed December 11, 2017).
2 http://www.openbugs.net/w/FrontPage (accessed December 11, 2017).
3 http://cadms.ucdavis.edu/diagnostictests/2dept1p.html (accessed December 11, 
2017).
FigUre 1 | The tracheal wash [TW; (a)] and bronchoalveolar lavage fluid [BALF; (B)] neutrophil percentage histograms among Group 1 and Group 3 horses. Group 
1 included clinically healthy control horses without signs potentially related to respiratory disease (n = 33), and Group 3 included horses that had both cough and 
nasal discharge and/or highest mucus score (3/3) confirming respiratory disease (n = 42).
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betabuster4 in R© 3.3.05 (R 2016) and were as follows: p1a = 99.70, 
p1b = 6.19; p2a = 2.08, p2b = 10.73; Se1a = 99.70, Se1b = 6.19; 
Sp1a  =  47.53, Sp1b  =  20.94; Se2a  =  23.90, Se2b  =  5.04; and 
Sp2a = 42.57, Sp2b = 5.62. Non-informative [beta (1,1)] priors, 
which allowed all values between 0 and 1 to have equal probability, 
were used for test 2 (BAL). After discarding the first 5,000 samples 
as burn-in, the next 150,000 iterations for inferences about Se, Sp, 
and prevalence were used. The model convergence was assessed 
by visual inspection of trace plots and running three chains from 
dispersed initial values.
resUlTs
The median age of all horses (n  =  154) was 10  years (range 
1–26  years). Breeds included the Finnhorse (n  =  48), other 
Coldblood (n = 10), Warmblood (n = 41), Standardbred (n = 35), 
and pony (n = 20). Of these horses, 121 had one or several acute or 
chronic signs potentially related to respiratory disease including 
cough (n = 69), nasal discharge (n = 43), fever (n = 2), epistaxis 
related to exercise (n = 8), or poor performance (n = 66). Based 
on the history, clinical examination, airway endoscopy, and 
sample cytology, most horses of Group 3 were diagnosed with 
equine asthma [severe asthma (RAO; n = 25) and mild asthma 
(IAD; n = 7)], exercise induced pulmonary hemorrhage (EIPH; 
n = 1), other diagnosis related to respiratory tract (n = 8), and 
undetermined diagnosis (n  =  1). The seventy-nine horses in 
Group 2 had varying diagnoses including mild asthma (n = 40), 
severe asthma (n = 13), EIPH (n = 2), other diagnosis related to 
respiratory tract (n = 8), other diagnosis not related to respiratory 
tract (n = 6), and undetermined diagnosis (n = 10).
The distributions of TW and BALF neutrophil percentage in 
Group 1 and Group 3 are presented in Figure 1. The neutrophil 
percentages in the TW and BALF samples of all three groups are 
presented in Figure 2. Of the other cell types, only macrophage 
4 http://rdrr.io/cran/epiR/man/epi.betabuster.html (accessed December 11, 2017).
5 http://www.r-project.org/ (accessed December 11, 2017).
percentages differed among groups for both TW and BALF 
samples, although in some horses the eosinophils and mast cells 
were above the reference values of 1% and 2%, respectively (Table 1). 
Most horses in this study had neutrophilic lung inflammation, thus 
the study concentrated on TW and BALF neutrophils. Detailed 
data on the horses and TW and BALF cytology results regarding 
other cell types than neutrophils are presented in Table 1.
Categorized TW and BALF neutrophil cytology results of all 
horses (n = 154) that were based on the neutrophil cutoff values 
of 20% for TW and 5% for BALF were significantly associated 
with each other (Fisher’s exact P < 0.001), but 17.5% of the horses 
were classified differently by the two compared tests (Table 2). 
The agreement of these two tests for neutrophil cytology assessed 
by the kappa value was 0.652 (95% CI 0.537–0.768), which 
indicated substantial agreement (18). The quantity of mucus 
in the trachea correlated with both TW (P <  0.001, Spearman 
ρ = 0.634) and BALF (P < 0.001, ρ = 0.415) neutrophil percent-
ages. Additionally, neutrophil (P < 0.001, ρ = 0.667), eosinophil 
(P = 0.002, ρ = 0.327), and macrophage (P < 0.001, ρ = 0.371) 
percentages correlated between TW and BALF.
We used Group 1 and Group 3 data to compare TW and BAL 
neutrophil percentage results and found that the AUC of the 
ROCs was 0.884 (95% CI 0.810–0.958) for TW, which indicated 
a moderately accurate test. In comparison, the AUC of the ROCs 
of 0.685 (95% CI 0.565–0.805) for BAL indicated a less accurate 
test. The TW neutrophil percentage histogram was bimodal 
(Figure  1) but some obviously diseased horses, as assessed by 
history, physical examination, and endoscopy mucus score, had 
low TW neutrophil percentages. Both Se and Sp values were 
optimized at cutoff of 17.7% (Youden’s J value) where they both 
were approximately 80% in the two-graph ROC curve for TW 
neutrophil percentage (Figure 3A). It can be seen from the graph 
that the target Se of 90% can be reached with a neutrophil cutoff 
of approximately 40%, and the Sp value would decline to approxi-
mately 70%. On the other hand, the BALF neutrophil percentage 
histogram (Figure 1B) revealed that most of the control and the 
diseased horses had low values, and only a few of the diseased 
horses had a high percentage of neutrophils. The two-graph ROC 
FigUre 2 | The tracheal wash [TW; (a)] and bronchoalveolar lavage fluid [BALF; (B)] neutrophil percentage among three groups of horses. Group 1 included 
clinically healthy control horses without signs potentially related to respiratory disease (n = 33). Group 2 included horses that had at least one of the following signs: 
cough, nasal discharge, epistaxis, fever or poor performance, and did not belong to Group 1 or Group 3 (n = 79). Group 3 included horses that had both cough and 
nasal discharge and/or highest mucus score (3/3) confirming respiratory disease (n = 42). The significant differences between groups (Dunn’s non-parametric 
comparison) are presented. Each box represents the interquartile range (25th to 75th percentiles), the central horizontal line is the median value, and the whiskers 
represent the range. Outliers are marked by black points.
TaBle 1 | The signalement, endoscopy mucus score (0−3), blood leukocyte 
count, plasma fibrinogen concentration, and tracheal wash (TW) and 





















Endoscopy mucus score; median 
(range) 
0 (0−2) 1 (0−2) 2 (0−3)
TW eosinophil%; median [IQR] 0.0 [0.0] 0.0 [0.4] 0.0 [0.0]
TW basophil%; median [IQR] 0.0 [0.0] 0.0 [0.0] 0.0 [0.0]
TW lymphocyte%; median [IQR] 2.0 [3.3] 3.6 [3.6] 2.0 [6.7]
TW macrophage%; median [IQR] 37.4 [49.3] 34.2 [62.2]a 15.4 [48.3]a
BALF eosinophil%; median [IQR] 0.0 [0.4] 0.0 [0.4] 0.0 [0.4]
BALF mast cell%; median [IQR] 3.0 [2.6] 2.4 [2.3] 1.4 [1.9]
BALF lymphocyte%; median [IQR] 51.4 [17.0] 44.9 [18.6] 52.7 [24.9]
BALF macrophage%; median [IQR] 41.4 [19.9]b 43.7 [19.5]c 31.1 [18.3]b,c
Fibrinogen (g/L; ref. < 4 g/L) 3.4 [0.6] 3.5 [1.0] 3.6 [1.3]
Total blood leukocyte count (×109/L) 7.6 [1.7] 7.2 [2.1] 8.5 [3.3]
Group 1: clinically healthy control horses without signs potentially related to respiratory 
disease. Group 2: horses with at least one of the following signs: cough, nasal 
discharge, epistaxis, fever or poor performance, and did not belong to either Group 
1 or Group 3. Group 3: horses with both cough and nasal discharge and/or highest 
mucus score (3/3) confirming respiratory disease. All horses (n = 154) that had been 
subject to both TW and BAL sampling at rest during 2009−2015 in Helsinki University 
Equine Teaching Hospital were included. The significant differences between groups 




TaBle 2 | Cross tabulation table showing the number (%) of horses within each 
diagnostic class of tracheal wash (TW) and bronchoalveolar lavage fluid (BALF) 
cytology results of all horses (n = 154).
TW > 20% TW ≤ 20% Total
BALF > 5% 57 (37.0%) 4 (2.6%) 61 
BALF ≤ 5% 23 (14.9%) 70 (45.5%) 93 
Total 80 74 154 (100%)
Diagnostic cutoff values (neutrophil percentage of the total quantity of inflammatory 
cells) are set at 20% for TW and 5% for BALF.
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50%. It can be seen from the graph that a target Se of 90% can 
be reached with cutoff of around 1%, whereas the Sp declined 
to approximately 0%. At the cutoff of 5%, the Sp is around 80%, 
whereas Se is only approximately 50%.
The median Se and Sp obtained by the Bayesian models 
for Group 3 (diseased) were 86.3% (95% probability interval 
78.9–92.4) and 72.5% (95% PI: 61.5–81.8), respectively, for 
TW neutrophil percentages. The corresponding values for the 
BALF neutrophil percentages were 92.4% (95% PI: 80.1–99.5) 
and 58.4% (95% PI: 4.6–97.5), respectively. The median Se and 
Sp for Group 1 (non-diseased) were 83.0% (95% PI: 66.5–93.7) 
and 89.2% (95% PI: 80.3–95.4), respectively, for TW neutrophil 
percentages. The corresponding values for BALF neutrophil 
percentages were 51.5% (95% PI: 4.7–96.6) and 81.1% (95% PI: 
64.7–94.6). The model with non-informative priors gave 90.5% 
prevalence in the diseased population (95% PI: 83.1–95.9) and 
12.1% in the non-diseased population (95% PI: 2.7–27.7).
With the neutrophil cutoff values obtained from two-graph 
ROC curves (17.7% for TW and 7% for BALF), crosstabulation 
analysis of TW and BALF cytology results for Group 2 (n = 79) 
horses was performed, and the results are presented in Table 3. 
The TW and BALF test results for this group were significantly 
curve for BALF neutrophil percentages (Figure  3B) for both 
Se and Sp revealed that they were optimized at a cutoff of 7% 
(Youden’s J) with an Sp of approximately 90% but an Se of only 
TaBle 3 | Cross tabulation table showing the number (%) of horses within each 
diagnostic class of tracheal wash (TW) and bronchoalveolar lavage fluid (BALF) 
cytology results of Group 2 horses (n = 79).
TW > 17.7% TW ≤ 17.7% Total
BALF > 7% 28 (35.4%) 1 (1.3%) 29
BALF ≤ 7% 14 (17.7%) 36 (45.6%) 50
Total 42 37 79 (100%)
Diagnostic cutoff values (neutrophil percentage of the total quantity of inflammatory 
cells) are set to 17.7% for TW and 7% for BALF as estimated by two graph ROC 
curves.
FigUre 3 | Two-graph receiver operating characteristic (ROC) curves with sensitivity and specificity plotted against the neutrophil percentage of tracheal wash [TW; 
(a)] and bronchoalveolar lavage fluid [BALF; (B)] for horses in Group 1 and Group 3. See Figure 1 for group definitions.
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associated with each other (Fisher’s exact P < 0.001), but 19% of 
the horses were classified differently by the two tests (Table 2).
DiscUssiOn
We compared the cytology of TW and BALF tests in horses with 
or without signs related to respiratory disease in this study. Only 
17.5% of horses in our population had differing diagnostic inter-
pretation of airway inflammation between the TW and BAL based 
on the neutrophil percentages and using the conventional cutoff 
values (3, 4). When only the horses with clinically less distinct 
clinical respiratory signs (Group 2) were assessed with the cutoff 
values of the ROC curves, agreement was approximately similar 
between the two tests. Previously, Malikides et al. (5) reported a 
higher disagreement of 37% in diagnostic interpretation between 
TW and BALF neutrophil percentages for airway inflammation 
diagnosis in young Australian racehorses in training presenting 
with poor performance. Furthermore, the agreement between 
the two tests in our study population that was assessed by kappa 
value was considered good (22) or at least substantial or moderate 
(18, 23) in contrast to previously published study data (24). The 
TW test was reported to be more sensitive in detecting airway 
neutrophilia by Malikides et al. (5), which agrees with our finding 
in the present study. However, some caution is required in making 
this comparison. The sampling in the studies by Malikides et al. (5) 
and by Allen et al. (24) was performed after high-speed treadmill 
exercise in contrast to our horses which had been sampled at 
rest: this might have affected the results since exercise is known 
to increase the neutrophil percentage in TW (25). Furthermore, 
these studies investigated only racehorses (5) or older National 
Hunt horses (24) in contrast to our study population of mixed 
breeds, and environmental conditions were different than in our 
study. This might have had an effect on the results.
We also investigated the currently used cutoff values of neu-
trophils for TW and BALF to justify their use in clinical practice 
for diagnosing airway inflammation. A sensitive method with 
unanimous cutoff value is needed in daily clinical equine prac-
tice to classify accurately the horse as being either diseased or 
healthy, since the diagnosis of respiratory disease in horses is 
often challenging due to non-specific clinical signs, such as poor 
performance. The current cutoff values for different cell types in 
BALF have recently been challenged. It has been suggested that 
they would be too restrictive, and new cutoff values of either 
>10% neutrophils, >5% mast cells, or >5% eosinophils for 
BALF have been proposed for diagnosis of airway inflammation 
(4, 8–11). Our data revealed that a cutoff of 10% for neutrophils 
would have resulted in an Sp of 95%, but with an Se of only 
45%, thus indicating a high proportion of false-negative results. 
Regarding TW, the reference values for equine tracheal secre-
tions have not been fully defined since there is large variability 
in the cellular content of TW samples in healthy horses (26–28). 
In particular, the cutoff for neutrophils still remains unclear, and 
there seems to be an overlap between normal horses and horses 
with respiratory disease (26–28). A limit of 20% of neutrophils 
has been conventionally used (3, 29), but there is some variation 
in cutoff values between different laboratories. The results of 
this study suggest that the current cutoff values for neutrophils, 
20% for TW and 5% for BALF, would be still appropriate for 
use in clinical practice for the diagnosis of airway inflammation 
in order to achieve acceptable Se. However, the importance of 
TW or BALF cytology results for the final diagnosis should still 
always be determined in combination with the horse’s history, 
clinical examination and airway endoscopy findings, to improve 
the diagnostic accuracy (4).
Contrary to many previously published studies (5, 12–14), 
we found a good correlation between the neutrophil percentage 
7
Rossi et al. Comparison of TW and BAL Cytology in Horses
Frontiers in Veterinary Science | www.frontiersin.org March 2018 | Volume 5 | Article 61
of TW and BALF. A weak but statistically significant correlation 
was found between eosinophils and macrophages between the 
two methods. Based on these results and due to neutrophils, and 
subsequently macrophages, being the only cell types with signifi-
cant difference between groups in TW and BALF, we therefore 
concentrated on the neutrophilic airway inflammation type in 
this study. In future studies, other cell types could also be assessed 
similarly. We found no correlation between the two methods for 
mast cells, nor differences between groups in this study. Mast 
cells are mainly distributed in the small distal airways and alveoli, 
and thus are a rare finding in the trachea (13). The diagnostic 
significance of a particular percentage of mast cells in BALF is 
not fully defined. A large range of 0.7–12.3% (median 9%) of mast 
cells in BALF has been previously reported among horses with 
no clinical evidence of respiratory tract disease (30). Further-
more, the quantity of mucus in the trachea correlated positively 
to BALF and even more strongly to TW neutrophil percentage, 
as found previously by some (9) but not all studies (8, 11, 31). 
Earlier studies have indicated that healthy horses have either no 
visible mucus or only a few isolated spots in their trachea (8, 31). 
Our results suggest that visible mucus in the trachea is likely to 
indicate neutrophilic airway inflammation.
Although BAL has been a standard diagnostic procedure 
in horses since the 1980s, there are no standardized guidelines 
for all steps of the sampling or cytological interpretation, and 
the method used is also known to have a considerable effect 
on the results (4). The possible sources of variation include the 
instilled volume of fluid, the number of aliquots used, dwell-
ing time of fluid, lung area lavaged, aspiration of the aliquot of 
instilled fluid (manual or pump), handling and conservation of 
the samples and finally, cytological analysis of the BALF and 
reporting the results. According to the expert consensus regard-
ing IAD, TW cytology is not considered an appropriate alterna-
tive to BALF cytology for the diagnosis or airway inflammation 
because BAL is considered to be a more sensitive and specific 
method to detect lower airway inflammation (4) contrary to our 
results. If BAL remains the recommended method of sampling, 
then standardization of the procedure must be implemented. 
However, the TW and BALF cytology of the large number of 
clinical cases in our study suggest that TW cytology is still at 
least comparable or even superior, easy, and an affordable tool 
in daily clinical equine practice, at least in cases of neutrophilic 
lung inflammation. Moreover, the Se and Sp of TW seem to be 
generally superior to those of BAL as analyzed by both conven-
tional statistics and Bayesian modeling.
Some limitations of the study need to be pointed out. 
The horses were client-owned true clinical cases and thus 
lived in varying stable conditions, were managed differently, 
and transported to the hospital over varying distances. The 
environmental factors including organic dust are known to 
have an influence on the severity of clinical signs and airway 
neutrophilia (4), which might have had an effect on the results. 
Unfortunately, we were not able to collect this information. 
Moreover, the possible gender or breed differences were not 
considered in this study. These data were collected over sev-
eral years, thus we were not able to have the same clinician 
performing the sampling of horses at all times. However, the 
TW and BALF collecting procedures are in routine use in our 
hospital setting, and therefore we assume minor variability in 
the sampling technique that was used over this time period. 
Moreover, a single experienced technician examined all the 
cytology slides. Counting 400 cells/slide is currently recom-
mended (32); however, our samples were analyzed in a clinical 
diagnostic laboratory and only 300 cells/slide were counted, 
which might have had an effect on the results. Furthermore, 
the results might have been affected by a systematic error due 
to a single technician performing the counts. Unfortunately, 
automated cell counters for equine TW or BALF samples are 
not available. The BAL was performed in only one lung (right 
side) on all horses. Recently, Depecker et al. (11) suggested that 
BAL performed only on one lung might not be representative 
of the contralateral lung on the same horse. Therefore, it would 
be important to sample both lungs to aid the diagnosis of 
lower airway inflammation, especially in those cases for which 
the first lung’s cytology is normal. The scoring of the mucus 
accumulation in the trachea in this study was performed sub-
jectively from 0 to 3 by the clinicians performing the sampling. 
This has been in routine use in our hospital although a more 
detailed scoring from 0 to 5 is recommended (33).
We conclude that TW and BALF neutrophil percentages 
correlated well in our patient material with naturally occurring 
respiratory disease of varying severity and in healthy horses 
indicating that either method is sufficient to detect airway neutro-
philia with TW being more sensitive and specific. We also suggest 
that the currently used neutrophil cutoff values of 20% for TW 
and 5% for BALF would still be appropriate to use in clinical work 
for the diagnosis of airway inflammation. Our understanding of 
normal respiratory tract cytology is still evolving from clinical 
experience and research, and the most useful sampling method 
will be dependent on the type and the severity of the suspected 
disease process in the individual horse.
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